These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11836397)

  • 1. Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice.
    Tran RK; Lieu PT; Aguilar S; Wagner EK; Bloom DC
    J Virol; 2002 Mar; 76(5):2199-205. PubMed ID: 11836397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells.
    Lieu PT; Wagner EK
    J Virol; 2000 Mar; 74(6):2770-6. PubMed ID: 10684293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The herpes simplex virus type 1 major capsid protein (VP5-UL19) promoter contains two cis-acting elements influencing late expression.
    Huang CJ; Wagner EK
    J Virol; 1994 Sep; 68(9):5738-47. PubMed ID: 8057455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons.
    Miranda-Saksena M; Armati P; Boadle RA; Holland DJ; Cunningham AL
    J Virol; 2000 Feb; 74(4):1827-39. PubMed ID: 10644356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of single hydrophobic residue I27, L35, F39, L58, L65, L67, or L71 in the N terminus of VP5 abolishes interaction with the scaffold protein and prevents closure of herpes simplex virus type 1 capsid shells.
    Walters JN; Sexton GL; McCaffery JM; Desai P
    J Virol; 2003 Apr; 77(7):4043-59. PubMed ID: 12634364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.
    Kato A; Ando T; Oda S; Watanabe M; Koyanagi N; Arii J; Kawaguchi Y
    J Virol; 2016 Jun; 90(12):5622-5635. PubMed ID: 27030266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of gamma(1)34.5 transcripts and latency-associated transcripts.
    Lee LY; Schaffer PA
    J Virol; 1998 May; 72(5):4250-64. PubMed ID: 9557715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of sequences downstream of the TATA box of the herpes simplex virus type 1 major capsid protein (VP5/UL19) promoter.
    Huang CJ; Goodart SA; Rice MK; Guzowski JF; Wagner EK
    J Virol; 1993 Sep; 67(9):5109-16. PubMed ID: 8394439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-site mutations encoding residues 34 and 78 of the major capsid protein (VP5) of herpes simplex virus type 1 are important for overcoming a blocked maturation cleavage site of the capsid scaffold proteins.
    Warner SC; Desai P; Person S
    Virology; 2000 Dec; 278(1):217-26. PubMed ID: 11112496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2.
    Jiang X; Brown D; Osorio N; Hsiang C; BenMohamed L; Wechsler SL
    J Neurovirol; 2016 Feb; 22(1):38-49. PubMed ID: 26069184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate-early expression of the herpes simplex virus type 1 ICP27 transcript is not critical for efficient replication in vitro or in vivo.
    Sun A; Devi-Rao GV; Rice MK; Gary LW; Bloom DC; Sandri-Goldin RM; Ghazal P; Wagner EK
    J Virol; 2004 Oct; 78(19):10470-8. PubMed ID: 15367613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulence.
    Cassady KA; Gross M; Gillespie GY; Roizman B
    J Virol; 2002 Feb; 76(3):942-9. PubMed ID: 11773369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second site mutations in the N-terminus of the major capsid protein (VP5) overcome a block at the maturation cleavage site of the capsid scaffold proteins of herpes simplex virus type 1.
    Desai P; Person S
    Virology; 1999 Sep; 261(2):357-66. PubMed ID: 10497121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
    Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
    Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-association of herpes simplex virus type 1 ICP35 is via coiled-coil interactions and promotes stable interaction with the major capsid protein.
    Pelletier A; Dô F; Brisebois JJ; Lagacé L; Cordingley MG
    J Virol; 1997 Jul; 71(7):5197-208. PubMed ID: 9188587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins.
    Rixon FJ; Addison C; McGregor A; Macnab SJ; Nicholson P; Preston VG; Tatman JD
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2251-60. PubMed ID: 8811025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery.
    Kato A; Shindo K; Maruzuru Y; Kawaguchi Y
    J Virol; 2014 Mar; 88(5):2775-85. PubMed ID: 24352467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a.
    Nicholson P; Addison C; Cross AM; Kennard J; Preston VG; Rixon FJ
    J Gen Virol; 1994 May; 75 ( Pt 5)():1091-9. PubMed ID: 8176370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes Simplex Virus 1-Specific CD8
    Treat BR; Bidula SM; St Leger AJ; Hendricks RL; Kinchington PR
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.